These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 31201794

  • 41. Acute bilateral endophthalmitis following bilateral intravitreal bevacizumab (avastin) injection.
    Tabatabaii A, Ahmadraji A, Khodabande A, Mansouri M.
    Middle East Afr J Ophthalmol; 2013; 20(1):87-8. PubMed ID: 23580860
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.
    VanderBeek BL, Bonaffini SG, Ma L.
    Ophthalmology; 2015 Nov; 122(11):2311-2315.e1. PubMed ID: 26281823
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. LONG-TERM VISUAL OUTCOMES AND CLINICAL FEATURES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTION-RELATED ENDOPHTHALMITIS.
    Rayess N, Obeid A, Storey PP, Juliano J, Rahimy E, Moshfeghi AA, Garg S, Hsu J.
    Retina; 2019 Nov; 39(11):2070-2076. PubMed ID: 30157114
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes.
    Simunovic MP, Rush RB, Hunyor AP, Chang AA.
    Br J Ophthalmol; 2012 Jun; 96(6):862-6. PubMed ID: 22446145
    [Abstract] [Full Text] [Related]

  • 57. Coagulase-negative staphylococcal endophthalmitis: clinical severity and outcomes based on speciation.
    Adeghate JO, Yadav S, Kowalski RP, Juhász E, Kristóf K, Olsen KR, Bergren RL, Knickelbein JE, Chhablani J, Martel JN, Anetakis A, Dansingani KK, Rosin B, Gallagher DS, Prensky C, Eller AW, Friberg T, Sahel JA, Errera MH.
    Can J Ophthalmol; 2024 Aug; 59(4):e371-e377. PubMed ID: 37321555
    [Abstract] [Full Text] [Related]

  • 58. International Practice Patterns for the Management of Acute Postsurgical and Postintravitreal Injection Endophthalmitis: European Vitreo-Retinal Society Endophthalmitis Study Report 1.
    Soliman MK, Gini G, Kuhn F, Iros M, Parolini B, Ozdek S, Michalewska Z, Bopp S, Adelman RA, Sallam AB, European Vitreo-Retinal Society Endophthalmitis Study Group.
    Ophthalmol Retina; 2019 Jun; 3(6):461-467. PubMed ID: 31043364
    [Abstract] [Full Text] [Related]

  • 59. Endophthalmitis following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy: Changes in Incidence and Outcomes over a 9-Year Period.
    Pancholy M, Storey PP, Levin HJ, Obeid A, Patel SN, Kuley B, Hsu J, Spirn MJ, Fineman M, Klufas MA, Gupta O, Ho AC, Garg SJ.
    Curr Eye Res; 2021 Sep; 46(9):1370-1377. PubMed ID: 33522314
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.